Possible scenario
Clinical Evidence Test
18% Chance
The business becomes increasingly dependent on proving that scans detect clinically meaningful conditions without creating excessive false positives. Given prior concerns about full-body screening, published outcomes and referral data become central to adoption by physicians, employers, and regulators.
Secondary impacts
- Healthcare +0.1%
Portfolio impact
S&P 500+0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.